S&P 500   4,599.15 (+1.34%)
DOW   35,290.62 (+2.05%)
QQQ   386.20 (+0.80%)
AAPL   166.21 (+2.70%)
MSFT   324.12 (+0.34%)
FB   317.22 (+3.38%)
GOOGL   2,861.49 (+0.76%)
AMZN   3,459.50 (+2.06%)
TSLA   1,009.21 (-0.57%)
NVDA   295.77 (-3.64%)
BABA   122.08 (+9.04%)
NIO   32.22 (+0.22%)
CGC   10.16 (+1.70%)
AMD   137.75 (-4.35%)
GE   96.76 (+4.30%)
MU   82.68 (+1.30%)
T   23.45 (-0.04%)
F   19.36 (+1.15%)
DIS   150.54 (+2.95%)
PFE   52.17 (-3.87%)
AMC   29.15 (+0.48%)
ACB   5.96 (+2.41%)
BA   205.77 (+3.67%)
S&P 500   4,599.15 (+1.34%)
DOW   35,290.62 (+2.05%)
QQQ   386.20 (+0.80%)
AAPL   166.21 (+2.70%)
MSFT   324.12 (+0.34%)
FB   317.22 (+3.38%)
GOOGL   2,861.49 (+0.76%)
AMZN   3,459.50 (+2.06%)
TSLA   1,009.21 (-0.57%)
NVDA   295.77 (-3.64%)
BABA   122.08 (+9.04%)
NIO   32.22 (+0.22%)
CGC   10.16 (+1.70%)
AMD   137.75 (-4.35%)
GE   96.76 (+4.30%)
MU   82.68 (+1.30%)
T   23.45 (-0.04%)
F   19.36 (+1.15%)
DIS   150.54 (+2.95%)
PFE   52.17 (-3.87%)
AMC   29.15 (+0.48%)
ACB   5.96 (+2.41%)
BA   205.77 (+3.67%)
S&P 500   4,599.15 (+1.34%)
DOW   35,290.62 (+2.05%)
QQQ   386.20 (+0.80%)
AAPL   166.21 (+2.70%)
MSFT   324.12 (+0.34%)
FB   317.22 (+3.38%)
GOOGL   2,861.49 (+0.76%)
AMZN   3,459.50 (+2.06%)
TSLA   1,009.21 (-0.57%)
NVDA   295.77 (-3.64%)
BABA   122.08 (+9.04%)
NIO   32.22 (+0.22%)
CGC   10.16 (+1.70%)
AMD   137.75 (-4.35%)
GE   96.76 (+4.30%)
MU   82.68 (+1.30%)
T   23.45 (-0.04%)
F   19.36 (+1.15%)
DIS   150.54 (+2.95%)
PFE   52.17 (-3.87%)
AMC   29.15 (+0.48%)
ACB   5.96 (+2.41%)
BA   205.77 (+3.67%)
S&P 500   4,599.15 (+1.34%)
DOW   35,290.62 (+2.05%)
QQQ   386.20 (+0.80%)
AAPL   166.21 (+2.70%)
MSFT   324.12 (+0.34%)
FB   317.22 (+3.38%)
GOOGL   2,861.49 (+0.76%)
AMZN   3,459.50 (+2.06%)
TSLA   1,009.21 (-0.57%)
NVDA   295.77 (-3.64%)
BABA   122.08 (+9.04%)
NIO   32.22 (+0.22%)
CGC   10.16 (+1.70%)
AMD   137.75 (-4.35%)
GE   96.76 (+4.30%)
MU   82.68 (+1.30%)
T   23.45 (-0.04%)
F   19.36 (+1.15%)
DIS   150.54 (+2.95%)
PFE   52.17 (-3.87%)
AMC   29.15 (+0.48%)
ACB   5.96 (+2.41%)
BA   205.77 (+3.67%)
NASDAQ:CMLT

CM Life Sciences III Stock Forecast, Price & News

$9.97
+0.01 (+0.10%)
(As of 12/6/2021 01:02 PM ET)
Add
Compare
Today's Range
$9.97
▼
$9.97
50-Day Range
$9.91
▼
$9.98
52-Week Range
$9.81
▼
$11.10
Volume
500 shs
Average Volume
243,316 shs
Market Capitalization
$206.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive CMLT News and Ratings via Email

Sign-up to receive the latest news and ratings for CM Life Sciences III and its competitors with MarketBeat's FREE daily newsletter.


About CM Life Sciences III

CM Life Sciences III Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York.

Headlines

EQRx and CM Life Sciences III Announce Effectiveness of Form S-4 Registration Statement and Stockholder Meeting Details to Vote on Proposed Business Combination
December 2, 2021 |  finance.yahoo.com
EQRx to Present at the 4th Annual Evercore ISI HealthCONx Conference
November 29, 2021 |  finance.yahoo.com
CM Life Sciences III Inc. (NASDAQ:CMLT) Sees Significant Growth in Short Interest
November 18, 2021 |  americanbankingnews.com
CM Life Sciences III Inc. Cl A
October 28, 2021 |  wsj.com
EQRx and Absci Announce Partnership to Discover and Develop Next-Generation Protein-Based Drugs
October 6, 2021 |  finance.yahoo.com
EQRx Appoints Kathy Giusti to Board of Directors
September 27, 2021 |  finance.yahoo.com
CM Life Sciences III Inc - Class A Shares Close in on 52-Week Low - Market Mover
September 22, 2021 |  nasdaq.com
EQRx Announces Presentation of Updated Data from Pivotal Phase 3 Study of Anti-PD-L1 Antibody Sugemalimab in Combination with Chemotherapy as a First-Line Treatment for Stage IV NSCLC
September 13, 2021 |  finance.yahoo.com
EQRx to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
September 7, 2021 |  finance.yahoo.com
CM Life Sciences III Inc - Class A Shares Approach 52-Week Low - Market Mover
August 28, 2021 |  nasdaq.com
Keith Meister-backed SPAC to merge with biotech firm EQRx in $3.65 bln deal
August 6, 2021 |  nasdaq.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CMLT
Previous Symbol
CUSIP
N/A
CIK
1843762
Web
iii.cmlifesciencesspac.com
Phone
212-474-6745
Fax
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($3.48) per share
Price / Book
-2.86

Profitability

EPS (Most Recent Fiscal Year)
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.03
Quick Ratio
1.03

Price-To-Earnings

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A

Miscellaneous

Outstanding Shares
20,725,000
Free Float
N/A
Market Cap
$206.63 million
Optionable
Not Optionable

Company Calendar

Today
12/06/2021
Fiscal Year End
12/31/2021

MarketRank™

Overall MarketRank™

0.33 out of 5 stars

Medical Sector

1341st out of 1,388 stocks

Pharmaceutical Preparations Industry

650th out of 670 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












CM Life Sciences III (NASDAQ:CMLT) Frequently Asked Questions

Are investors shorting CM Life Sciences III?

CM Life Sciences III saw a increase in short interest during the month of October. As of October 29th, there was short interest totaling 920,400 shares, an increase of 76.0% from the October 14th total of 522,900 shares. Based on an average daily volume of 316,800 shares, the short-interest ratio is currently 2.9 days.
View CM Life Sciences III's Short Interest.

Who are CM Life Sciences III's key executives?

CM Life Sciences III's management team includes the following people:
  • Mr. Eli Decatur Casdin, CEO & Director
  • Mr. Brian Emes, CFO & Sec. (Age 38)
  • Dr. Shaun Kevin Rodriguez, Chief Strategy Officer (Age 43)

What is CM Life Sciences III's stock symbol?

CM Life Sciences III trades on the NASDAQ under the ticker symbol "CMLT."

Who are CM Life Sciences III's major shareholders?

CM Life Sciences III's stock is owned by a variety of retail and institutional investors. Top institutional investors include Hsbc Holdings PLC (10.62%), Weiss Asset Management LP (9.79%), Franklin Resources Inc. (9.65%), SB Management Ltd (9.30%), Millennium Management LLC (5.92%) and Sculptor Capital LP (5.03%).

Which major investors are selling CM Life Sciences III stock?

CMLT stock was sold by a variety of institutional investors in the last quarter, including SB Management Ltd, HighTower Advisors LLC, Beryl Capital Management LLC, CNH Partners LLC, and BlackRock Inc..

Which major investors are buying CM Life Sciences III stock?

CMLT stock was bought by a variety of institutional investors in the last quarter, including Hsbc Holdings PLC, Weiss Asset Management LP, Franklin Resources Inc., Moore Capital Management LP, Sculptor Capital LP, Farallon Capital Management LLC, Magnetar Financial LLC, and BlueCrest Capital Management Ltd.

How do I buy shares of CM Life Sciences III?

Shares of CMLT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CM Life Sciences III's stock price today?

One share of CMLT stock can currently be purchased for approximately $9.97.

How much money does CM Life Sciences III make?

CM Life Sciences III has a market capitalization of $206.63 million.

What is CM Life Sciences III's official website?

The official website for CM Life Sciences III is iii.cmlifesciencesspac.com.

Where are CM Life Sciences III's headquarters?

CM Life Sciences III is headquartered at 667 MADISON AVENUE, NEW YORK NY, 10065.

How can I contact CM Life Sciences III?

CM Life Sciences III's mailing address is 667 MADISON AVENUE, NEW YORK NY, 10065. The company can be reached via phone at 212-474-6745.


This page was last updated on 12/6/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.